![New Lung Cancer Considered episode, the use of ICIs in the treatment of molecular driven NSCLC](https://oncodaily.com/pub/uploads/2024/07/GTvSKAXX0AAPx9b-1280x720.jpg)
Photo from IASLC/X
Jul 31, 2024, 09:17
New Lung Cancer Considered episode, the use of ICIs in the treatment of molecular driven NSCLC
IASLC shared on X:
“In this Lung Cancer Considered episode, Narjust Florez and 2 esteemed oncology colleagues discuss an evolving hot topic: the use of immune checkpoint inhibitors in the treatment of patients with molecular driven NSCLC. With guests Erin Schenk and Biagio Ricciuti.”
Narjust Florez shared IASLC’s post, adding:
“Amazing discussion about use of Immuno-oncology in patients with Lung Cancer with driver mutations.
Highly recommend this episode, so much learning for these two great guests Drs. Erin Schenk and Biagio Ricciuti.”
Source: IASLC/X and Narjust Florez/X
Aug 11, 2024, 05:12
Aug 11, 2024, 04:55
Aug 11, 2024, 04:37
Aug 11, 2024, 02:26